Evidence map›Paper›PMID 42495334›Full record

ArticleACS omega2026

Cellulose Acetate Nanoparticles as Eco-Friendly Photosensitizers for Antimicrobial Photodynamic Inactivation.

Raphael S Flores, Gabriella Miessi, Priscila S Cavalheri, Emmanuel S C Miguel, Regiane G Lima, Samuel L Oliveira, Anderson R L Caires

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raphael S FloresOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Gabriella MiessiOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Priscila S CavalheriOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Emmanuel S C MiguelOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Regiane G LimaOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
Samuel L OliveiraOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.ORCID https://orcid.org/0000-0002-8616-772X
Anderson R L CairesOptics and Photonics Group, Institute of Physics, Federal University of Mato Grosso do Sul, P.O. Box 549, Campo Grande, Mato Grosso do Sul 79070-900, Brazil.ORCID https://orcid.org/0000-0002-2602-9480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance has emerged as a critical global health issue, demanding sustainable alternatives to conventional antibiotics. This study aimed to develop and evaluate cellulose acetate nanoparticles (NPs-CA) as eco-friendly photosensitizers for antimicrobial photodynamic inactivation (aPDI). NPs-CA were synthesized via nanoprecipitation, producing spherical and monodisperse nanoparticles with a mean hydrodynamic diameter of 268 ± 8 nm. The particles' photophysical and morphological properties were characterized by UV-vis, SEM, and DLS. ROS generation was assessed using dihydroethidium (DHE) assays. Acute toxicity was assessed using

Identifiers

PMID42495334
PMCPMC13393358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.